Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Tsui, Teresa ^a   Boon, Heather ^a   Boecker, Andreas ^b   Kachan, Natasha ^a   Krahn, Murray ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Decision making; Means ends chain analysis; Natural health products; Osteoarthritis

Indexed keywords

BROMELAIN; CHONDROITIN; DIMETHYL SULFONE; GLUCOSAMINE; NATURAL PRODUCT;

ADULT; AGED; ARTICLE; CANADA; CLINICAL ARTICLE; CONSUMER; DECISION MAKING; EVIDENCE BASED MEDICINE; FAMILY; FEMALE; FRIEND; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MALE; OSTEOARTHRITIS; PERSONNEL;

EID: 84867898462     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-198     Document Type: Article

References (38)

1. Natural Health Product Regulations http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/index_e.html.
2. Canada's Functional Food and Natural Health Products Industry AAFC Number 10393E 2007, Agriculture and Agri-food Canada.
3. Ipsos-Reid Baseline Natural Health Products Survey Among Consumers 2005, Ottawa, Canada: Health Canada, Ipsos-Reid.
4. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Metaanalysis. Integr Cancer Ther 2012, 11(3):187-203. Epub 2011 Oct 21, 10.1177/1534735411423920, 22019489.
5. Dayhew M, Wilkinson JM, Simpson MD. Complementary and alternative medicine and the search for knowledge by conventional health care practitioners. Contemp Nurse 2009, 33(1):41-49. 10.5172/conu.33.1.41, 19715494.
6. Lawson B, Putnam W, Nicol K, Archibald G, Mackillop J, Conter H, Frail D. Managing osteoarthritis. Medication use among seniors in the community. Can Fam Physician 2004, 50:1664-1670. 2214529, 15648382.
7. Gregory PJ, Sperry M, Wilson AF. Dietary supplements for osteoarthritis. Am Fam Physician 2008, 77(2):177-184.
8. Shaver JL, Wilbur J, Lee H, Robinson FP, Wang E. Self-reported medication and herb/supplement use by women with and without fibromyalgia. J Womens Health (Larchmt) 2009, 18(5):709-716.
9. Wilk V, Palmer HD, Stosic RG, McLachlan AJ. Evidence and practice in the self-management of low back pain: findings from an Australian internet-based survey. Clin J Pain 2010, 26(6):533-540. 10.1097/AJP.0b013e3181dc7abb, 20551729.
10. Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract 2005, 22(2):170-176. Epub 2005 Feb 2014, 10.1093/fampra/cmh723, 15710640.
11. Boon H, Kachan N, Boecker A. Use of Natural Health Products: How Does Being "Natural" Affect Choice?. Med Decis Making 2012, Epub ahead of print.
12. Caspi O, Koithan M, Criddle MW. Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making 2004, 24(1):64-79. 10.1177/0272989X03261567, 15005956.
13. Verhoef MJ, Mulkins A, Carlson LE, Hilsden RJ, Kania A. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study. Integr Cancer Ther 2007, 6(4):345-353. 10.1177/1534735407309482, 18048882.
14. Balneaves LG, Truant TL, Kelly M, Verhoef MJ, Davison BJ. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer 2007, 15(8):973-983. 10.1007/s00520-007-0282-3, 17609997.
15. Balneaves LG, Weeks L, Seely D. Patient decision-making about complementary and alternative medicine in cancer management: context and process. Curr Oncol 2008, 15(Suppl 2):s94-s100. 2528558, 18769576.
16. Irwin A, Wynne B. Misunderstanding science? The public reconstruction of science and technology 1996, Cambridge: Cambridge University Press.
17. Sturgis P, Allum N. Science in Society: Re-Evaluating the Deficit Model of Public Attitudes. Public Understanding of Science 2004, 13(1):55-74.
18. Miller S. Public understanding of science at the crossroads. Public Understanding of Science 2001, 10(1):115-120.
19. Gross AG. The roles of rhetoric in the public understanding of science. Public Understanding of Science 1994, 3(1):3-23.
20. Lewenstein BV. When science meets the public 1992, Washington: American Association for the Advancement of Science.
21. Grunert KG, Grunert SC. Measuring subjective meaning structures by the laddering method: Theoretical considerations and methodological problems. Intern J of Research in Marketing 1995, 12:209-225.
22. Reynolds TJ, Olson JC. Understanding Consumer Decision Making. The Means-End Approach to Marketing and Advertising Strategy 2001, Mahwah, New Jersey: Lawrence Erlbaum Associates, Inc.
23. Gutman J. A means-end chain model based on consumer categorization processes. J Mark 1982, 46:60-72.
24. MECanalyst Cognitive consumer mapping software, user guide. In.; rev. 0.4_en MECanalyst.
25. Reynolds TJ, Gutman J. Laddering theory, method, analysis, and interpretation. J Advertising Res 1988, 28:11-31.
26. Natural Standard Database Evidence-based validated grading rationale Somerville, MA, USA, www.naturalstandard.com, Natural Standard Database.
27. Ezzy D, Liamputtong P. Qualitative Research Methods 2005, South Melbourne, Australia: Oxford University Press, 2.
28. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine, How to Practice and Teach EBM 2000, London, U.K.: Churchill Livingstone, 2.
29. Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol 2006, 4(4):157-169. 10.2310/7200.2006.019, 17022924.
30. Boon H, Brown JB, Gavin A, Westlake K. Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Making 2003, 23(6):471-479. 10.1177/0272989X03259815, 14672107.
31. Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 2007, 7:25. 10.1186/1472-6882-7-25, 2000907, 17683580.
32. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res 1999, 9(5):639-653. 10.1177/104973299129122135, 10558372.
33. Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2003, 2(3):212-216. 10.1177/1534735403256207, 15035882.
34. Rozin P. The meaning of "natural": process more important than content. Psychol Sci 2005, 16(8):652-658. 10.1111/j.1467-9280.2005.01589.x, 16102069.
35. Rozin P, Spranca M, Krieger Z, Neuhaus R, Surillo D, Swerdlin A, Wood K. Preference for natural: instrumental and ideational/moral motivations, and the contrast between foods and medicines. Appetite 2004, 43(2):147-154. 10.1016/j.appet.2004.03.005, 15458801.
36. Chema SK, Marks LA, Parcell JL, Bredahl M. Marketing Biotech Soybeans with Functional Health Attributes. Can J Agric Econ 2006, 54:685-703.
37. Vannoppen J, Verbeke W, Huylenbroeck GV, Viaene J. Consumer Valuation of Short Market Channels for Fresh Food Through Laddering. Journal of International Food and Agribusiness Marketing 2001, 12(1):41-69.
38. Grindrod KA, Marra CA, Colley L, Cibere J, Tsuyuki RT, Esdaile JM, Gastonguay L, Kopec J. After patients are diagnosed with knee osteoarthritis, what do they do?. Arthritis Care Res (Hoboken) 2010, 62(4):510-515.